| Symbol |
Name |
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANKRD36B
|
ankyrin repeat domain 36B
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCN2
|
cellular communication network factor 2
|
|
CD274
|
CD274 molecule
|
|
CDK16
|
cyclin-dependent kinase 16
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
ETFA
|
electron-transfer-flavoprotein, alpha polypeptide
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL24
|
interleukin 24
|
|
KIF20A
|
kinesin family member 20A
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MARCH3
|
membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MUC1
|
mucin 1, cell surface associated
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RBM45
|
RNA binding motif protein 45
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
SCD5
|
stearoyl-CoA desaturase 5
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
TLR4
|
toll-like receptor 4
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
ZNF35
|
zinc finger protein 35
|
|
ZNF654
|
zinc finger protein 654
|
